<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006431</url>
  </required_header>
  <id_info>
    <org_study_id>Local/2018</org_study_id>
    <nct_id>NCT04006431</nct_id>
  </id_info>
  <brief_title>Prostate Embolization in Chronically Surveyed Patients: Effectiveness of Unilateral vs. Bilateral Embolization</brief_title>
  <official_title>Prostate Embolization in Chronically Surveyed Patients: Effectiveness of Unilateral vs. Bilateral Embolization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prostate embolization is an alternative treatment to trans urethral prostate resection in the&#xD;
      context of benign prostatic hypertrophy. This embolization treatment is also of interest in&#xD;
      patients with chronic anuria surveyed in relation to their prostatic hypertrophy for&#xD;
      disundation. This survey causes discomfort and urinary tract infection. It is a population&#xD;
      with tortuous arteries, a severe atherosclerotic overload making embolizations complex and&#xD;
      long. Often, only unilateral embolization is possible. The purpose of this study is to&#xD;
      compare the effectiveness in terms of disundation of unilateral vs. bilateral embolization of&#xD;
      the prostatic arteries&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prostate embolization is an alternative treatment to trans urethral prostate resection in the&#xD;
      context of benign prostatic hypertrophy. This embolization treatment is also of interest in&#xD;
      patients with chronic anuria surveyed in relation to their prostatic hypertrophy for&#xD;
      disundation. This survey causes discomfort and urinary tract infection. It is a population&#xD;
      with tortuous arteries, a severe atherosclerotic overload making embolizations complex and&#xD;
      long. Often, only unilateral embolization is possible. The purpose of this study is to&#xD;
      compare the effectiveness in terms of disundation of unilateral vs. bilateral embolization of&#xD;
      the prostatic arteries.&#xD;
&#xD;
      Method of observation or investigation chosen:&#xD;
&#xD;
      Retrospective, observational collection with division of patients into two groups according&#xD;
      to unilateral or bilateral embolization of the porstatic arteries.&#xD;
&#xD;
      Origin and nature of the data Patient's medical record: imaging stored in the PACS to confirm&#xD;
      unilateral or bilateral embolization, perform measurements of prostate volume, urological&#xD;
      medical record to see the effectiveness of embolization in terms of disundation, comfort of&#xD;
      life, tolerance of embolization, effectiveness in terms of urination (IPSS score)&#xD;
&#xD;
      Data flow mode:&#xD;
&#xD;
      Data stored in redcap.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 4, 2019</start_date>
  <completion_date type="Actual">April 4, 2020</completion_date>
  <primary_completion_date type="Actual">April 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the effectiveness of embolization</measure>
    <time_frame>at one month</time_frame>
    <description>International prostate score symptomsScore</description>
  </primary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Unilateral vs Bilateral Embolization of the Prostate Arteries</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>embolization</intervention_name>
    <description>Retrospective, observational collection with division of patients into two groups according to unilateral or bilateral embolization of the porstatic arteries.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly patients (&gt;70 years of age) with contraindications to surgery, chronically probed&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elderly patients (&gt;70 years old)&#xD;
&#xD;
          -  with contraindications to surgery,&#xD;
&#xD;
          -  with a chronic urinary catheterization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;70 years old&#xD;
&#xD;
          -  without contraindications to surgery&#xD;
&#xD;
          -  without chronic urinary catheterization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

